Loading chat...

WA HB1689

Bill

Status

Passed

3/24/2022

Primary Sponsor

Amy Walen

Click for details

Origin

House of Representatives

2021-2022 Regular Session

AI Summary

Legislative Description

Exempting biomarker testing from prior authorization for patients with late stage cancer.

INSURANCE

Last Action

Effective date 6/9/2022.

3/24/2022

Committee Referrals

Rules2/24/2022
Health & Long Term Care2/10/2022
Rules1/27/2022
Health Care and Wellness1/10/2022

Full Bill Text

No bill text available